Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma
Condition(s):Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)Last Updated:March 7, 2024Active, not recruiting